Author： Mitler M.M. Hayduk R.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.25, Iss.11, 2002-01, pp. : 791-809
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Benefits and Risks of Pharmacotherapy for Dysthymia: A Systematic Appraisal of the Evidence
By De Lima M.S.
Drug Safety, Vol. 26, Iss. 1, 2003-01 ,pp. :
Access to resources
Recommend
Risks and benefits of perioperative -blockers
Reactions Weekly, Vol. 1, Iss. 1203, 2008-01 ,pp. :
Risks and benefits of allergen immunotherapy
By Rogala Barbara Glück Joanna
Expert Opinion on Drug Safety, Vol. 8, Iss. 3, 2009-05 ,pp. :
Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. :
Antidepressants: Update on Benefits and Risks
Current Psychopharmacology, Vol. 1, Iss. 3, 2012-08 ,pp. :